0001753373 2026-01-01 2026-06-30 0001753373 dei:FormerAddressMember 2026-01-01 2026-06-30 0001753373 2026-08-21 0001753373 2026-06-30 0001753373 2025-12-31 0001753373 us-gaap:NonrelatedPartyMember 2026-06-30 0001753373 us-gaap:NonrelatedPartyMember 2025-12-31 0001753373 us-gaap:RelatedPartyMember 2026-06-30 0001753373 us-gaap:RelatedPartyMember 2025-12-31 0001753373 us-gaap:SeriesBPreferredStockMember 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001753373 us-gaap:SeriesAPreferredStockMember 2026-06-30 0001753373 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001753373 2026-04-01 2026-06-30 0001753373 2025-04-01 2025-06-30 0001753373 2025-01-01 2025-06-30 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001753373 us-gaap:CommonStockMember 2025-12-31 0001753373 us-gaap:TreasuryStockCommonMember 2025-12-31 0001753373 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001753373 us-gaap:RetainedEarningsMember 2025-12-31 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001753373 us-gaap:CommonStockMember 2026-03-31 0001753373 us-gaap:TreasuryStockCommonMember 2026-03-31 0001753373 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001753373 us-gaap:RetainedEarningsMember 2026-03-31 0001753373 2026-03-31 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001753373 us-gaap:CommonStockMember 2024-12-31 0001753373 us-gaap:TreasuryStockCommonMember 2024-12-31 0001753373 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001753373 us-gaap:RetainedEarningsMember 2024-12-31 0001753373 2024-12-31 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001753373 us-gaap:CommonStockMember 2025-03-31 0001753373 us-gaap:TreasuryStockCommonMember 2025-03-31 0001753373 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001753373 us-gaap:RetainedEarningsMember 2025-03-31 0001753373 2025-03-31 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001753373 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001753373 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001753373 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001753373 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001753373 2026-01-01 2026-03-31 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001753373 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001753373 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0001753373 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001753373 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001753373 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001753373 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001753373 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001753373 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001753373 2025-01-01 2025-03-31 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001753373 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001753373 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0001753373 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001753373 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001753373 us-gaap:CommonStockMember 2026-06-30 0001753373 us-gaap:TreasuryStockCommonMember 2026-06-30 0001753373 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001753373 us-gaap:RetainedEarningsMember 2026-06-30 0001753373 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001753373 us-gaap:CommonStockMember 2025-06-30 0001753373 us-gaap:TreasuryStockCommonMember 2025-06-30 0001753373 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001753373 us-gaap:RetainedEarningsMember 2025-06-30 0001753373 2025-06-30 0001753373 MTWO:KomodoCapitalMember 2024-06-30 0001753373 MTWO:NTMMineralsLimitedMember 2024-06-30 0001753373 MTWO:NTMMineralsLimitedMember 2024-06-30 2024-06-30 0001753373 MTWO:OfftakeAgreementMember 2024-06-30 2024-06-30 0001753373 2025-07-28 0001753373 us-gaap:FairValueInputsLevel3Member 2026-06-30 0001753373 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001753373 srt:ChiefFinancialOfficerMember MTWO:ConsultingAgreementMember 2026-01-01 2026-06-30 0001753373 MTWO:ExecutiveChairmanAndChiefFinancialOfficerMember 2026-06-30 0001753373 MTWO:ExecutiveChairmanAndChiefFinancialOfficerMember 2025-12-31 0001753373 MTWO:ConsultingAgreementMember srt:ChiefExecutiveOfficerMember 2026-01-01 2026-06-30 0001753373 MTWO:FormerAgreementMember srt:ChiefExecutiveOfficerMember 2025-01-01 2025-12-31 0001753373 MTWO:ConsultingAgreementMember MTWO:PresidentAndChiefExecutiveOfficerMember 2026-01-01 2026-06-30 0001753373 MTWO:ConsultingAgreementMember srt:ChiefExecutiveOfficerMember 2025-01-01 2025-12-31 0001753373 srt:ChiefExecutiveOfficerMember 2026-06-30 0001753373 srt:ChiefExecutiveOfficerMember 2025-12-31 0001753373 MTWO:NotePayableAgreementMember srt:DirectorMember 2026-01-01 2026-06-30 0001753373 srt:DirectorMember 2026-01-01 2026-06-30 0001753373 MTWO:NotePayableAgreementMember srt:DirectorMember 2025-01-01 2025-12-31 0001753373 srt:ChiefFinancialOfficerMember 2026-01-01 2026-06-30 0001753373 srt:MinimumMember MTWO:VendorMember 2026-06-30 0001753373 MTWO:VendorMember 2026-06-30 0001753373 MTWO:ExecutiveChairmanMember MTWO:VendorMember 2026-06-30 0001753373 MTWO:TwoVendorsMember 2025-12-31 0001753373 2023-11-24 2023-11-24 0001753373 2023-11-24 0001753373 MTWO:ConvertibleNotePayableAgreementMember 2026-01-01 2026-06-30 0001753373 us-gaap:CommonStockMember MTWO:ConvertibleNotePayableAgreementMember 2026-01-01 2026-06-30 0001753373 us-gaap:CommonStockMember MTWO:ConvertibleNotePayableAgreementMember 2026-06-30 0001753373 MTWO:TwoThousandTwentySixTermSheetsMember 2026-06-30 0001753373 MTWO:TwoThousandTwentySixTermSheetsMember 2026-01-01 2026-06-30 0001753373 MTWO:ConvertibleNoteMember 2025-12-31 0001753373 MTWO:ConvertibleNoteMember 2026-01-01 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2026-06-30 0001753373 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001753373 MTWO:ConvertibleNoteMember 2026-06-30 0001753373 us-gaap:MeasurementInputSharePriceMember 2026-06-30 0001753373 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001753373 us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001753373 us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001753373 us-gaap:WarrantMember 2025-12-31 0001753373 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001753373 us-gaap:WarrantMember 2026-06-30 0001753373 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2026-06-30 0001753373 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2026-06-30 0001753373 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2026-06-30 0001753373 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2026-06-30 0001753373 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2026-06-30 0001753373 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2026-06-30 0001753373 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2026-06-30 0001753373 2026-01-01 0001753373 us-gaap:SeriesAPreferredStockMember 2026-01-01 0001753373 2026-01-01 2026-01-01 0001753373 2026-01-26 0001753373 us-gaap:SeriesBPreferredStockMember 2026-01-26 0001753373 us-gaap:SeriesBPreferredStockMember 2026-04-22 0001753373 us-gaap:SeriesBPreferredStockMember 2026-04-23 0001753373 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-06-30 0001753373 us-gaap:CashMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001753373 us-gaap:CashMember 2026-01-01 2026-06-30 0001753373 MTWO:ConvertibleNoteHolderMember 2026-01-01 2026-06-30 0001753373 MTWO:ConvertibleNoteHolderMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2026-08-15 0001753373 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-01 2026-08-15 0001753373 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001753373 2024-11-30 2024-11-30 0001753373 us-gaap:SubsequentEventMember 2026-07-27 0001753373 us-gaap:SubsequentEventMember 2026-07-28 0001753373 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-01 2026-08-19 0001753373 us-gaap:PreferredStockMember us-gaap:SubsequentEventMember 2026-07-01 2026-08-19 0001753373 us-gaap:SubsequentEventMember 2026-07-01 2026-08-19 0001753373 MTWO:TwoThousandTwentySixTermSheetsMember us-gaap:SubsequentEventMember 2026-07-01 2026-08-19 0001753373 MTWO:TermSheetsAndExtensionNotesMember us-gaap:SubsequentEventMember 2026-07-01 2026-08-19 iso4217:USD shares iso4217:USD shares pure utr:t false Q2 --12-31 0001753373

10-Q true 2026-06-30 2026 false 333-229748 M2i GLOBAL, INC. NV 37-1904036 885 Tahoe Blvd. Incline Village NV 89451 (775) 909-6000 3827 S Carson St. P.O. Box 40 Carson City NV 89701 Yes Yes true true Non-accelerated Filer false false 0.001 953662377

54661

515438

36336

102068

90997

617506

90997

617506

991572

934276

2391772

1867610

2391772

1867610

205000

230000

1462937

507733

500000

4137500

5551281

7677119

5551281

7677119

312500

10000000

0.001

100000

100

750

557

1000000000

0.001

824074734

716021604

824075

716022

435000

10640321

5964871

-16489781

-13618106

-5460284

-7372113

90997

617506

385228

255198

756817

610119

1284891

1112298

2926033

1807138

1670119

1367496

3682850

2417257

-1670119

-1367496

-3682850

-2417257

350263

363357

508908

29194

55243

47996

69125

684426

-55243

811175

-69125

-985693

-1422739

-2871675

-2486382

-0.00

791974572

637201539

761818087

618520151

100000

100

716021604

716022

-435000

5964871

-13618106

-7372113

7864834

7865

12435

20300

22935203

22935

274065

297000

83333 83333

876213

876

11441

12317

15556

984

1000

-12500000 -12500 -300000 -312500 428633 428633

-1885982

100000

100

760182298

760182

-435000

7073794

-15504088

-8105012

32188333

32188

203779

235967

5476139

5476

245496

250972

599

4625856

4625857

-1584374 -1584374

24942445

24942

-24942

83333 83333

1285519

1286

17380

18666

-985693

100000

100

557

824074734

824075

-435000

10640321

-16489781

-5460284

100000

100

583954525

583955

-435000

3757155

-6618639

-2712429

29800000

29800

82200

112000

142861 142861

-1063643

100000

100

613754525

613755

-435000

3982216

-7682282

-3521211

100000

100

613754525

613755

-435000

3982216

-7682282

-3521211

10431177

10431

359969

370400

54700000

54700

175078

229778

1154600 1154600

-1422739

100000

100

678885702

678886

-435000

5671863

-9105021

-3189172

100000

100

678885702

678886

-435000

5671863

-9105021

-3189172

-2871675

-2486382

166666

540000 229778 2500

350263

508908

-65732

-35472

781637

429612

524161 268893

-1650150

-1522627

689373 1154600

625262

500000

35158

87896

1189373

1727124

-460777

204497

515438

36022

54661

240519

718358 30984 312500 4137500

Note 1 — Description of Organization and Business Operations M2i Global, Inc. (formerly known as “Inky Inc.”) (the “Company”) was incorporated in the State of Nevada on June 12, 2018. On June 7, 2023, the Company filed with the Secretary of State of Nevada an Amendment to the Certificate of Incorporation to change its corporate name from “Inky, Inc.” to “M2i Global, Inc.”. The Company was formerly engaged in developing mobile software applications for smartphones and tablet devices. During May 2023, the Company became the sole shareholder of U.S. Minerals and Metals Corp., a Nevada corporation (“USMM”) through the issuance of preferred and common shares for cash. Concurrently, the Company shifted its operations to specialization in the development and execution of a complete global value supply chain for critical minerals for the U.S. government and U.S. free trade partners. The Company’s vision is to develop and execute a complete global value supply chain for critical minerals for the United States government and certain trading partners of the United States. To implement this vision, the Company intends to operate three key business divisions as set forth below: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">M2i Mining, Processing & Refining: a business engaged in sourcing, extraction, processing, refining, transporting and selling primary minerals and metals;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">M2i Scrap & Recycling: a business engaged in the collection, processing, transporting and selling of scrap, recycled and reused metals; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">M2i Government and Defense Industrial Base: a business engaged in aligning with U.S. policy to facilitate participation in U.S. government programs such as the creation and management of a Strategic Minerals Reserve as an enhancement of the U.S. government’s National Defense Stockpile.</td></tr> </table> On June 30, 2024, the Company and Komodo Capital (“Komodo”), a company specializing in the development and execution of a complete global value supply chain for critical minerals for the U.S. government and U.S. free trade partners, entered into a strategic partnership (the “Strategic Partnership”), in order for Komodo to use its relationships to provide the Company with access to various critical minerals, with an ultimate goal of supplying the U.S. government and U.S. free trade partners with these critical minerals. Komodo Capital also offers comprehensive advisory services. The Company issued 8.0 million shares of common stock valued at $800 as part of this agreement. On June 30, 2024, the Company and NTM Minerals Limited (“NTM”), a company specializing in the development and execution of a complete global value supply chain for critical minerals for the U.S. government and U.S. free trade partners, entered into an exclusive offtake agreement (the “Offtake Agreement”), in which NTM will provide for 88,000 tonnes of copper, currently valued at approximately $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn6n6_c20240630__20240630__us-gaap--TypeOfArrangementAxis__custom--NTMMineralsLimitedMember_zUiD9WQybPS" title="Value of assets purchased">850 million. The Company is granted offtake rights for a maximum of 88,000 tonnes of copper that is sourced from the Redbank tenements in return for <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_pn5n6_c20240630__20240630__us-gaap--TypeOfArrangementAxis__custom--NTMMineralsLimitedMember_zzLSuyZv1Lte" title="Common stock issued for purchase of assets">12.0 million shares of the Company’s common stock valued at $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20240630__20240630__us-gaap--TypeOfArrangementAxis__custom--OfftakeAgreementMember_zTgdADCPot5i" title="Stock issued value for purchase of assets">1,200 as part of the agreement. NTM will receive additional payments for incremental resource increases or upgrades from the Redbank tenements. M2i retains the option to participate in production pre-funding opportunities. On July 28, 2025, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) among the Company, Volato Group, Inc., a Delaware corporation (“Volato”), and Volato Merger Subsidiary, Inc., a Nevada corporation and wholly-owned subsidiary of Volato (“Merger Sub”). Pursuant to the Merger Agreement, and subject to the satisfaction or waiver of the conditions therein, at the effective time of the merger, Merger Sub will be merged with and into the Company with the Company surviving as a wholly owned subsidiary of Volato. The Merger Agreement contains customary representations, warranties and covenants of the parties, and is subject to approval by the Company’s stockholders, approval by the holders of Volato’s Class A common stock, $0.0001 par value per share receipt of certain regulatory approvals and other customary closing conditions. The Company’s board of directors unanimously approved the Merger Agreement and determined that the Merger is advisable and in the best interests of the Company and its stockholders. On June 4, 2026, the Company received a written notice (the “Termination Notice”) from Volato, purporting to terminate that certain Agreement and Plan of Merger Reorganization, dated as of July 28, 2025, by and among the Company. The Termination Notice alleges that termination is effective as of June 4, 2026, and asserts certain purported grounds for termination, pursuant to Section 10.1 of the Merger Agreement. As of the termination date, the Merger Agreement is of no further force or effect such that the respective right and obligations of all parties under the Merger Agreement are terminated. On July 9, 2026 both parties signed a Mutual Termination and Release Agreement.

8000000.0

800

88000

850000000

88000

12000000.0

1200

0.0001

Note 2 – Going Concern The accompanying unaudited consolidated condensed financial statements have been prepared in conformity with generally accepted accounting principles generally accepted in the United States of America (“U.S. GAAP”), which contemplate continuation of the Company as a going concern. The Company had no revenues and incurred losses during the six months ended June 30, 2026 and 2025 totaling $2,871,675 and $2,486,382, respectively. In addition, the accumulated deficit amounted to $16,489,781 and $13,618,106 as of June 30, 2026 and December 31, 2025, respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management intends to fund ongoing operations through a combination of existing cash balances, future capital raises through debt and equity, and cash receipts from anticipated revenue. However, the Company had cash of $54,661 at June 30, 2026 and used $1,650,150 of cash in operating activities during the six months then ended. Management’s plans are not considered probable of being effectively implemented and therefore do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date the condensed consolidated financial statements are issued. In order to continue as a going concern, the Company will need, among other things, additional capital resources. The Company is significantly dependent upon its ability to secure additional equity and/or debt financing. There are no assurances that the Company will be successful in obtaining additional capital. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.

-2871675

-2486382

-16489781

-13618106

54661

-1650150

Note 3 — Summary of Significant Accounting Policies Change of Fiscal Year The Board of Directors determined that it was advisable and in the best interests of the Company to change the Company’s fiscal year end from November 30 to December 31 in order to align the Company’s fiscal reporting period with the calendar year. Our results of operations and changes in stockholders’ deficit presented in this Form 10Q are for the three and six months ended June 30, 2026 and 2025, unless otherwise noted. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and the interim reporting rules of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report Form filed with the SEC on Form 10-KT filed with the SEC on April 15, 2026. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, U.S. Minerals and Metals Corp. (“USMM”). All intercompany balances and transactions have been eliminated in consolidation. Segment Reporting The Company operates as a single reportable segment. The Chief Operating Decision Makers (“CODMs”) have been identified as the Chief Executive Officer and the Chief Financial Officer, who review the total assets and loss of Company to make decisions about allocating resources and assessing financial performances. The key measure of segment loss reviewed by the CODMs are the operating expenses. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at a measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. Described below are the three levels of input that may be used to measure fair value: Level 1 – Quoted market prices in active markets for identical assets or liabilities. Level 2 – Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3 – Unobservable inputs that are used when little or no market data is available. Under the fair value hierarchy in ASC Topic 820-10-35, the Company’s derivative liability is measured using Level 3 inputs. The derivative liability was $374,650 as of June 30, 2026 and $507,733 as of December 31, 2025. Cash and Cash Equivalents The Company considers all highly liquid instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. The Company maintains its cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC provides coverage of up to $250,000 per depositor, per financial institution, for the aggregate total of depositors’ interest and non-interest-bearing accounts. Income Taxes In accordance with FASB ASC Topic 740, “Income Taxes,” the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. In addition, the Company’s management performs an evaluation of all uncertain income tax positions taken or expected to be taken in the course of preparing the Company’s income tax returns to determine whether the income tax positions meet a “more likely than not” standard of being sustained under examination by the applicable taxing authorities. This evaluation is required to be performed for all open tax years, as defined by the various statutes of limitations, for federal and state purposes. If the Company has interest or penalties associated with insufficient taxes paid, such expenses are reported in income tax expense. Debt Issuance Costs The Company accounts for debt issuance costs in accordance with ASU 2015-03. This guidance requires direct and incremental costs associated with the issuance of debt instruments such as legal fees, printing costs and underwriters’ fees, among others, paid to parties other than creditors, are reported and presented as a reduction of debt on the consolidated balance sheets. Debt issuance costs and premiums or discounts are amortized over the term of the respective financing arrangements using the effective interest method. Amortization of these amounts is included as a component of interest expense net, in the consolidated statements of operations. Convertible Debt In accordance with ASC 470 the Company records its convertible notes at the aggregate principal amount, less discount. The Company will amortize the debt discount over the life of the convertible notes as additional non-cash expense utilizing the effective interest rate. Warrants The Company accounts for the warrants issued in connection with the Series B Preferred Stocks in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Based on its evaluation of the terms of the warrants, the Company determined that such instruments qualify for liability classification. Accordingly, the warrants are recorded as derivative liability and are subsequently remeasured at fair value with level 3 unobservable inputs. Basic and Diluted Loss Per Share Basic earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Deferred Stock-Based Compensation Deferred stock-based compensation shall be deemed to be those transactions carried out by the Company which involve shares of the Company issued for future services. Treasury Stock Treasury stock represents shares of the Company’s common stock that have been issued and subsequently reacquired by the Company. Treasury stock is recorded at cost and presented as a reduction of stockholders’ deficit. Related Party The Company records all related party transactions in accordance with ASC 850-10. Recently Issued Accounting Standards In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2023-09 (“ASU 2023-09”), Income Taxes, which enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. The amendments are effective for fiscal years beginning after December 15, 2024. Retrospective application is permitted. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosure. In November 2024, the FASB issued Accounting Standards Update (“ASU 2024-03”), Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures. Revenue Recognition The Company is currently pre-revenue. The Company will recognize revenues in accordance with ASC 606. Subsequent Events The Company has evaluated all transactions through the date the financial statements were issued for subsequent event disclosure or adjustment consideration.

Change of Fiscal Year The Board of Directors determined that it was advisable and in the best interests of the Company to change the Company’s fiscal year end from November 30 to December 31 in order to align the Company’s fiscal reporting period with the calendar year. Our results of operations and changes in stockholders’ deficit presented in this Form 10Q are for the three and six months ended June 30, 2026 and 2025, unless otherwise noted.

Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and the interim reporting rules of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report Form filed with the SEC on Form 10-KT filed with the SEC on April 15, 2026. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, U.S. Minerals and Metals Corp. (“USMM”). All intercompany balances and transactions have been eliminated in consolidation.

Segment Reporting The Company operates as a single reportable segment. The Chief Operating Decision Makers (“CODMs”) have been identified as the Chief Executive Officer and the Chief Financial Officer, who review the total assets and loss of Company to make decisions about allocating resources and assessing financial performances. The key measure of segment loss reviewed by the CODMs are the operating expenses.

Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at a measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. Described below are the three levels of input that may be used to measure fair value: Level 1 – Quoted market prices in active markets for identical assets or liabilities. Level 2 – Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3 – Unobservable inputs that are used when little or no market data is available. Under the fair value hierarchy in ASC Topic 820-10-35, the Company’s derivative liability is measured using Level 3 inputs. The derivative liability was $374,650 as of June 30, 2026 and $507,733 as of December 31, 2025.

374650

507733

Cash and Cash Equivalents The Company considers all highly liquid instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. The Company maintains its cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC provides coverage of up to $250,000 per depositor, per financial institution, for the aggregate total of depositors’ interest and non-interest-bearing accounts.

250000

Income Taxes In accordance with FASB ASC Topic 740, “Income Taxes,” the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. In addition, the Company’s management performs an evaluation of all uncertain income tax positions taken or expected to be taken in the course of preparing the Company’s income tax returns to determine whether the income tax positions meet a “more likely than not” standard of being sustained under examination by the applicable taxing authorities. This evaluation is required to be performed for all open tax years, as defined by the various statutes of limitations, for federal and state purposes. If the Company has interest or penalties associated with insufficient taxes paid, such expenses are reported in income tax expense.

Debt Issuance Costs The Company accounts for debt issuance costs in accordance with ASU 2015-03. This guidance requires direct and incremental costs associated with the issuance of debt instruments such as legal fees, printing costs and underwriters’ fees, among others, paid to parties other than creditors, are reported and presented as a reduction of debt on the consolidated balance sheets. Debt issuance costs and premiums or discounts are amortized over the term of the respective financing arrangements using the effective interest method. Amortization of these amounts is included as a component of interest expense net, in the consolidated statements of operations.

Convertible Debt In accordance with ASC 470 the Company records its convertible notes at the aggregate principal amount, less discount. The Company will amortize the debt discount over the life of the convertible notes as additional non-cash expense utilizing the effective interest rate. Warrants The Company accounts for the warrants issued in connection with the Series B Preferred Stocks in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Based on its evaluation of the terms of the warrants, the Company determined that such instruments qualify for liability classification. Accordingly, the warrants are recorded as derivative liability and are subsequently remeasured at fair value with level 3 unobservable inputs.

Basic and Diluted Loss Per Share Basic earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

Deferred Stock-Based Compensation Deferred stock-based compensation shall be deemed to be those transactions carried out by the Company which involve shares of the Company issued for future services.

Treasury Stock Treasury stock represents shares of the Company’s common stock that have been issued and subsequently reacquired by the Company. Treasury stock is recorded at cost and presented as a reduction of stockholders’ deficit. Related Party The Company records all related party transactions in accordance with ASC 850-10.

Recently Issued Accounting Standards In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2023-09 (“ASU 2023-09”), Income Taxes, which enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. The amendments are effective for fiscal years beginning after December 15, 2024. Retrospective application is permitted. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosure. In November 2024, the FASB issued Accounting Standards Update (“ASU 2024-03”), Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures.

Revenue Recognition The Company is currently pre-revenue. The Company will recognize revenues in accordance with ASC 606.

Subsequent Events The Company has evaluated all transactions through the date the financial statements were issued for subsequent event disclosure or adjustment consideration.

Note 4 — Commitments and Contingencies In June of 2025, a lawsuit was filed in state of Nevada against the Company by a former consultant for breach of contract, securities fraud and related claims stemming from a 2022 consulting agreement and stock agreements entered into with two companies owned by the consultant. In December 2025, the court entered a default judgment in the matter. In February 2026, the Company filed a motion to set aside the default judgment. In March 2026, the Company participated in a mediation with the plaintiff and entered into a long-term settlement agreement. Pursuant to the agreement, the Company agreed to transfer 12,500,000 shares of common stock to the plaintiff and the agreement further provided for mutual release of all claims against the Company. The Company filed a Form 8-K on March 23, 2026 regarding this legal matter. The shares of common stock were issued during the six months ended June 30, 2026 at a value of $312,500. There is no further obligation outstanding.

12500000

312500

Note 5 – Accounts Payable and Accrued Expenses During the six months ended June 30, 2026, the Company’s accounts payables and accrued expenses increased to $991,572 from $934,276 at the year ended December 31, 2025 for an increase of $57,286. The increase was due to the accrual of professional fees, and accounts payables as the Company continues to shift its operations a noted in Note 1 above.

991572

934276

57286

Note 6 — Related Party Transactions Under the terms of a consulting agreement with the Company’s Executive Chairman and CFO, the Company is obligated to compensate him $<span id="xdx_902_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zAELBandfud8" title="Compensation amount">43,667 per month, consisting of $<span id="xdx_90D_eus-gaap--PaymentsForCommissions_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zcHsRVJHU5B" title="Consultant fees">41,667 in consulting fees and a $<span id="xdx_900_ecustom--MonthlyAllowance_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z5nDqEzQFqXc" title="Monthly allowance">2,000 monthly allowance. During the six months ended June 30, 2026, the Company incurred $<span id="xdx_90F_eus-gaap--PaymentsForFees_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zsaCliezZhQd" title="Incurred expenses">262,000 in expenses related to the consulting agreement. During the six months ended June 30, 2026, the Company paid $<span id="xdx_903_ecustom--OtherConsultantFees_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z4yhTuCTcKF5" title="Other consultant fees">160,444. At the periods ended June 30, 2026 and December 31, 2025, the balance due to the Executive Chairman and CFO was $606,055 and $505,499, respectively. During the year ended December 31, 2025, the Board of Directors approved the accrual of interest payable on the unpaid consultant fees retroactive to August 1, 2024. During the six months ended June 30, 2026, the Company accrued $<span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zz2406nfjQ27" title="Accrued interest">21,060 interest. At the periods ending June 30, 2026 and December 31, 2025, the accrued interest payable due for unpaid consultant fees was $69,847 and $45,480, respectively. Under the terms of a consulting agreement with the Company’s President and Chief Executive Officer, the Company is obligated to compensate him $<span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zfqDydJe1Pka" title="Compensation amount">43,667 per month, consisting of $<span id="xdx_900_eus-gaap--PaymentsForCommissions_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zpK7XAgIuJl8" title="Consultant fees">41,667 in consulting fees and a $<span id="xdx_907_ecustom--MonthlyAllowance_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zVntpQJlXFi6" title="Monthly allowance">2,000 monthly allowance. During the year ended December 31, 2025, the Board of Directors approved the consulting fee to be increased to $<span id="xdx_900_ecustom--IncreaseInConsultantFees_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--FormerAgreementMember_zSBOa1o5xHy4" title="Increase in consultant fees">56,167 per month, consisting of $<span id="xdx_901_eus-gaap--PaymentsForCommissions_pp2d_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--FormerAgreementMember_zB0qiwwAm3g7" title="Consultant fees">54,167 in consulting fees and a $<span id="xdx_90F_ecustom--MonthlyAllowance_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--FormerAgreementMember_zv4cGFGSEQ85" title="Monthly allowance">2,000 monthly allowance. During the six months ended June 30, 2026, the Company incurred $<span id="xdx_905_eus-gaap--PaymentsForFees_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zL3Zb2z2VBO4" title="Incurred expenses">337,000 in expenses related to the consulting agreement. During the six months ended June 30, 2026, the Company paid $<span id="xdx_90D_eus-gaap--PaymentsForFees_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PresidentAndChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zq1YKZUCZsoi" title="Incurred expenses">141,167 consulting expense to the President and Chief Executive Officer. At the periods ended June 30, 2026 and December 31, 2025, $<span id="xdx_907_ecustom--UnpaidCompensation_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zskIUJcFIu32" title="Unpaid compensation">327,834 and $<span id="xdx_903_ecustom--UnpaidCompensation_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultingAgreementMember_zH3zvYonb5md" title="Unpaid compensation">132,001, respectively remained unpaid under the agreement. During the year ended December 31, 2025, the Board of Directors approved the accrual of interest payable on the unpaid consultant fees retroactive to August 1, 2024. During the six months ended June 30, 2026, the Company accrued $7,703 interest. At the periods ending June 30, 2026 and December 31, 2025, the accrued interest payable due for unpaid consultant fees was $26,756 and $18,230, respectively. Under the terms of agreements with the Company’s directors, the Company is obligated to compensate each of them $<span id="xdx_902_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember__us-gaap--RelatedPartyTransactionAxis__custom--NotePayableAgreementMember_zRosS0cdNfD4" title="Compensation amount">10,000 per month. During the six months ended June 30, 2026, the Company incurred $<span id="xdx_908_eus-gaap--InterestExpense_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember__us-gaap--RelatedPartyTransactionAxis__custom--NotePayableAgreementMember_z4IpGUtCqGF2" title="Interest expense">180,000 in expenses related to director agreements. During the six months ended June 30, 2026, the Company paid $0. At the periods ending June 30, 2026 and December 31, 2025, $<span id="xdx_904_ecustom--RemainedUnpaidAmount_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember__us-gaap--RelatedPartyTransactionAxis__custom--NotePayableAgreementMember_zCwVr1KeRzVe" title="Remained unpaid amount">640,000 and $<span id="xdx_909_ecustom--RemainedUnpaidAmount_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember__us-gaap--RelatedPartyTransactionAxis__custom--NotePayableAgreementMember_zWbAcwLEOk25" title="Remained unpaid amount">460,000, respectively remained unpaid. The Company reimburses related party business expenses. During the six months ended June 30, 2026, the Company incurred $<span id="xdx_906_eus-gaap--OperatingCostsAndExpenses_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefFinancialOfficerMember_zXnyqiHjJ8F4" title="Related party business expenses">39,852 related party business expenses with a director. As of June 30, 2026, the balance due to the director is $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember__us-gaap--RelatedPartyTransactionAxis__custom--NotePayableAgreementMember_zYQs2yPya8M6" title="Repayment of debt">21,512. As of June 30, 2026, the Company has an account payable to a vendor, who is a more than <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20260630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--VendorMember__srt--RangeAxis__srt--MinimumMember_zrEMh9VjQ1w4" title="Beneficial owner percentage">5% beneficial owner, in an amount of $350,000. The Company also has an account payable to a separate vendor, which is controlled by the Executive Chairman, in an amount of $<span id="xdx_90B_eus-gaap--AccountsPayableCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VendorMember__srt--TitleOfIndividualAxis__custom--ExecutiveChairmanMember_zm5LNYaXM4Xj" title="Account payable">350,000. At the end of December 31, 2025, the balances due to these two vendors was $350,000 each.

43667

41667

2000

262000

160444

606055

505499

21060

69847

45480

43667

41667

2000 56167

54167

2000

337000

141167

327834 132001

7703

26756

18230

10000

180000

640000 460000

39852

21512

0.05

350000

Note 7 — Debt Convertible Note Payable On November 24, 2023, the Company executed a 10% convertible note payable agreement with a principal amount of $250,000, net of an original issue discount of $20,000, resulting in proceeds of $230,000 (the “2023 Note”). The 2023 Note, which was scheduled to mature originally on November 24, 2024, is convertible by the holder at $0.50 per share of common stock for the first six months, then is convertible by the holder at 66% of the lowest traded price of the Company’s common stock for the ten days prior to conversion. The note contains certain default provisions which may increase the balance of the note by up to 150%. On November 22, 2024, the Company executed an extension of the 2023 Note from November 24, 2024 to May 24, 2025. On May 23, 2025, the Company executed an extension of the 2023 Note from May 24, 2025 to December 31, 2025. On March 23, 2026, the Company executed an extension of the 2023 Note from December 31, 2025 to September 30, 2026. During the six months ended June 30, 2026, the note holder converted $<span id="xdx_903_eus-gaap--DebtInstrumentRepaidPrincipal_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePayableAgreementMember_zAxL6vfdHGZf" title="Principal of conversion amount">25,000 principal and $<span id="xdx_90F_ecustom--DebtInterestConvertedIntoShares_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePayableAgreementMember_zhWeo7MvH1b8" title="Conversion of accrued interest">5,983 accrued interest into <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePayableAgreementMember_zl1tcOrrZ2wj" title="Common stock issued for convertible debt">2,161,732 shares of common stock. At June 30, 2026, the remaining principal balance is $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ConvertibleNotePayableAgreementMember_zdJjIZCmyZv4" title="Principal balance">205,000. During the six months period ending June 30, 2026, the Company accrued $10,986 in interest expense related to the 2023 Note. At the end of the six months period ending June 30, 2026, the accrued interest payable due on the 2023 Note is $52,912. Promissory Notes During the six months ending June 30, 2026, the Company executed six Promissory Notes with separate individuals for a total of $500,000 (the “2026 Promissory Notes”). In addition, each holder of the 2026 Promissory Notes is entitled to receive <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentySixTermSheetsMember_z76Kv3DhchGh" title="Shares conversion">500,000 shares of the Company’s common stock for each $100,000 of principal invested. Each holder can elect to have the outstanding principal and accrued interest convert into shares of common stock in subsequent financing at a conversion price equal to a <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentySixTermSheetsMember_zXrfAPfKLhAa" title="Discount percentage">25% discount to the price per share paid by investors in that financing. The 2026 Promissory Notes have a 90-day maturity date and a <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentySixTermSheetsMember_zO6nOvhm1vq5" title="Discount percentage">10% interest rate. Subsequent to the period ended June 30, 2026, the maturity was reached and an amendment to the 2026 Promissory Notes was prepared incorporating the 2026 Promissory Notes information and extended the maturity date to December 31, 2026. During the six months ended June 30, 2026, the Company accrued $6,301 in interest expense which is the balance currently due. The 2026 Promissory Notes described above were outstanding as of June 30, 2026. The 2,500,000 shares of common stock issuable to the holders in connection with their original investment were issued subsequent to June 30, 2026.

0.10

250000

20000

230000

2024-11-24

0.50

0.66

The note contains certain default provisions which may increase the balance of the note by up to 150%. On November 22, 2024, the Company executed an extension of the 2023 Note from November 24, 2024 to May 24, 2025. On May 23, 2025, the Company executed an extension of the 2023 Note from May 24, 2025 to December 31, 2025. On March 23, 2026, the Company executed an extension of the 2023 Note from December 31, 2025 to September 30, 2026.

25000

5983

2161732

205000

10986

52912

500000

100000

0.25

0.10

6301

2500000

Note 8 — Derivative Valuation Convertible Note In November 2023, the Company issued a convertible note (see Note 7). The conversion terms of the convertible note are based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Due to the exercise terms of the conversion feature becoming available on November 28, 2025, the conversion features in the note met the definition of a derivative and required bifurcation and liability classification at fair value. As of December 31, 2025, the derivative liability was $507,733. During the six months ended June 30, 2026, there was a decrease of the derivative liability to $<span id="xdx_901_ecustom--DerivativeFairValueOfDerivativeNetChange_iN_di_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zKa52W0KAV3g" title="Fair value of derivative liability">374,650 which represented a change in the fair value of the derivative of $133,083. The Company estimates the fair value of the embedded conversion feature using a Monte Carlo simulation. During the six months ended June 30, 2026, the Company had the following activity in the derivative liability account for the convertible debt: Schedule of Activity in the Derivative Liability Account <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Derivative liability at December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iS_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_z7vtVhT8VJD7" style="width: 16%; text-align: right" title="Derivative liability, balance">507,733</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">(Gain) loss on change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zvtP9sJ79Fah" style="border-bottom: Black 1pt solid; text-align: right" title="(Gain) loss on change in fair value">133,083</td><td style="padding-bottom: 1pt; text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Derivative liability at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zS7ru2GagLoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, balance">374,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-XVMZW_z8KMYNDLuq2l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">A summary of quantitative information with respect to valuation methodology and significant unobservable income used for the Company’s derivative liability that are categorized within Level 3 of fair value hierarchy for the six months ended June 30, 2026 is as follows: Schedule of Valuation Methodology and Significant Unobservable Income Used for the Company’s Derivative Liability <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Stock price at valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zjt87qQ3UMae" title="Stock price at valuation date">.03</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztJAAFM6ZDeh" title="Risk free interest rate">3.92</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock volatility factor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zvduGiRk6hD6" title="Stock volatility factor">139</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contractual terms (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_znlSTJyeYTfh" title="Derivative liability measurement">0.18</td><td style="text-align: left"> </td></tr> </table> Warrants During the six months ended June 30, 2026, the Company issued <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zAyzUrN1Ocl" title="Number of shares warrant issued">55,166,667 warrants to shareholders of the Company’s Series B Preferred Shares. The warrant holder is entitled to subscribe for and purchase shares of common stock based on the market value of the shares of common stock at time of exercise. The exercise terms of the conversion feature met the definition of a derivative and required bifurcation and liability classification at fair value. The Company estimates the fair value of the conversion feature using the Black Scholes Model. During the six months ended June 30, 2026, the Company had the following activity in the derivative liability account for the warrants: <p id="xdx_897_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAbA2n8jCLM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Schedule of Activity in the Derivative Liability Account <div id="xdx_C0C_gL3SODLAFVTTB-RJDZ_zqvw5zFrE8Yf"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Derivative liability at December 31, 2025</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zFPpABOziV9g" style="text-align: right" title="Derivative liability, balance">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify; padding-bottom: 1pt">(Gain) loss on change in fair value</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zKetcjGAyvPi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="(Gain) loss on change in fair value">1,088,287</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Derivative liability at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilities_iE_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_z6fXtSwx5Vt8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, balance">1,088,287</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </div> A summary of quantitative information with respect to valuation methodology and significant unobservable income used for the Company’s derivative liability that are categorized within Level 3 of fair value hierarchy for the six months ended June 30, 2026 is as follows: <p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6jXXiKTMERa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Schedule of Valuation Methodology and Significant Unobservable Income Used for the Company’s Derivative Liability <div id="xdx_C09_gL3FVAALMORAN-XVMZW_ztJwP6DoEEJ6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">Stock price at valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zuuLjBDRs94l" title="Stock price at valuation date">.020-<span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z2G8PUBPWze2" title="Stock price at valuation date">.027</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zmcKhBDorE94" title="Risk free interest rate">4.05%-<span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zTC9EbHxlipb" title="Risk free interest rate">4.19</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock volatility factor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z23rYNxT9jNc" title="Stock volatility factor">246% - <span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z5JgnMptFWKk" title="Stock volatility factor">247</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Contractual terms (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOspUlqZeaui" title="Derivative liability measurement">5</td><td style="text-align: left"> </td></tr> </table> </div>

507733

-374650

-133083

During the six months ended June 30, 2026, the Company had the following activity in the derivative liability account for the convertible debt: Schedule of Activity in the Derivative Liability Account <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Derivative liability at December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iS_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_z7vtVhT8VJD7" style="width: 16%; text-align: right" title="Derivative liability, balance">507,733</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">(Gain) loss on change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zvtP9sJ79Fah" style="border-bottom: Black 1pt solid; text-align: right" title="(Gain) loss on change in fair value">133,083</td><td style="padding-bottom: 1pt; text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Derivative liability at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zS7ru2GagLoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, balance">374,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Schedule of Activity in the Derivative Liability Account<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Derivative liability at December 31, 2025</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zFPpABOziV9g" style="text-align: right" title="Derivative liability, balance">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify; padding-bottom: 1pt">(Gain) loss on change in fair value</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zKetcjGAyvPi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="(Gain) loss on change in fair value">1,088,287</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Derivative liability at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilities_iE_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_z6fXtSwx5Vt8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, balance">1,088,287</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

507733

-133083

374650

<p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_gL3FVAALMORAN-XVMZW_z8KMYNDLuq2l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">A summary of quantitative information with respect to valuation methodology and significant unobservable income used for the Company’s derivative liability that are categorized within Level 3 of fair value hierarchy for the six months ended June 30, 2026 is as follows: Schedule of Valuation Methodology and Significant Unobservable Income Used for the Company’s Derivative Liability <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Stock price at valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zjt87qQ3UMae" title="Stock price at valuation date">.03</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztJAAFM6ZDeh" title="Risk free interest rate">3.92</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock volatility factor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zvduGiRk6hD6" title="Stock volatility factor">139</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contractual terms (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_znlSTJyeYTfh" title="Derivative liability measurement">0.18</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">Stock price at valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zuuLjBDRs94l" title="Stock price at valuation date">.020-<span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z2G8PUBPWze2" title="Stock price at valuation date">.027</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zmcKhBDorE94" title="Risk free interest rate">4.05%-<span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zTC9EbHxlipb" title="Risk free interest rate">4.19</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock volatility factor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z23rYNxT9jNc" title="Stock volatility factor">246% - <span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z5JgnMptFWKk" title="Stock volatility factor">247</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Contractual terms (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOspUlqZeaui" title="Derivative liability measurement">5</td><td style="text-align: left"> </td></tr> </table>

0.03

3.92

139

0.18

55166667

<p id="xdx_897_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAbA2n8jCLM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Schedule of Activity in the Derivative Liability Account <div id="xdx_C0C_gL3SODLAFVTTB-RJDZ_zqvw5zFrE8Yf"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Derivative liability at December 31, 2025</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zFPpABOziV9g" style="text-align: right" title="Derivative liability, balance">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify; padding-bottom: 1pt">(Gain) loss on change in fair value</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zKetcjGAyvPi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="(Gain) loss on change in fair value">1,088,287</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Derivative liability at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilities_iE_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_z6fXtSwx5Vt8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, balance">1,088,287</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </div> A summary of quantitative information with respect to valuation methodology and significant unobservable income used for the Company’s derivative liability that are categorized within Level 3 of fair value hierarchy for the six months ended June 30, 2026 is as follows: <p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6jXXiKTMERa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Schedule of Valuation Methodology and Significant Unobservable Income Used for the Company’s Derivative Liability <div id="xdx_C09_gL3FVAALMORAN-XVMZW_ztJwP6DoEEJ6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">Stock price at valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zuuLjBDRs94l" title="Stock price at valuation date">.020-<span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z2G8PUBPWze2" title="Stock price at valuation date">.027</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zmcKhBDorE94" title="Risk free interest rate">4.05%-<span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zTC9EbHxlipb" title="Risk free interest rate">4.19</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock volatility factor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z23rYNxT9jNc" title="Stock volatility factor">246% - <span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z5JgnMptFWKk" title="Stock volatility factor">247</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Contractual terms (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOspUlqZeaui" title="Derivative liability measurement">5</td><td style="text-align: left"> </td></tr> </table> </div>

1088287

<p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6jXXiKTMERa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Schedule of Valuation Methodology and Significant Unobservable Income Used for the Company’s Derivative Liability <div id="xdx_C09_gL3FVAALMORAN-XVMZW_ztJwP6DoEEJ6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">Stock price at valuation date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zuuLjBDRs94l" title="Stock price at valuation date">.020-<span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z2G8PUBPWze2" title="Stock price at valuation date">.027</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zmcKhBDorE94" title="Risk free interest rate">4.05%-<span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zTC9EbHxlipb" title="Risk free interest rate">4.19</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock volatility factor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z23rYNxT9jNc" title="Stock volatility factor">246% - <span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z5JgnMptFWKk" title="Stock volatility factor">247</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Contractual terms (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOspUlqZeaui" title="Derivative liability measurement">5</td><td style="text-align: left"> </td></tr> </table> </div>

0.020

0.027

4.05

4.19

246

247

Note 9 — Stockholders’ Deficit On January 1, 2026, the Company filed a Certificate of Amendment with the State of Nevada to increase the number of preferred shares authorized to issue to 10,000,000 preferred shares with a $0.001 par value. Of these 10,000,000 shares, 100,000 shares of Series A Preferred Stock have been issued in prior periods and these shares are super-voting with 10 votes per share. On January 26, 2026, the Company designated 500 of the remaining 9,900,000 shares as Series B Preferred Stock. On April 23, 2026, the Company filed a Certificate of Amendment with the State of Nevada to increase the number of Series B Preferred Shares from <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20260422__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zZf7MNl0N0ik" title="Increase the number of preferred shares">500 to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20260423__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEMyhh13Myhb" title="Increase the number of preferred shares">750. All other shares have one voting right. Preferred Stock Shares Issued for Cash During the six months ended June 30, 2026, the Company issued 550 shares of Series B Preferred Stock for cash received in prior periods totaling $4,137,500. The cash previously received was recorded as Unissued stock liability. The cash previously received was recorded as Unissued stock liability. During the six months ended June 30, 2026, the Company issued 55,166,167 warrants associated with the Series B Preferred Stock. (See Footnote 8) During the six months ended June 30, 2026, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zDWyyhNNSdK5">49 shares of Series B Preferred Stock for services rendered valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLMAgH8NpvLg">488,358. In addition, the Company recognized a gain on extinguishment of debt of $350,263 within other income in the accompanying condense statements of operations. The warrants associated with these Series B Preferred Stock have not yet been issued. Common Stock Shares Issued for Cash During the six months ended June 30, 2026, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zTOEEjUQhuP8" title="Number of shares issued">40,053,167 shares of common stock for cash received of $684,900. Shares Issued for Services During the six months ended June 30, 2026, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_z4Z0HjsZ7uBa" title="Number of shares issued for services">28,411,342 shares of common stock for services rendered valued at $547,972. Convertible Note Payable Conversion During the six months ended June 30, 2026, the convertible note holder (see Footnote 7) converted $25,000 principal and $5,983 accrued interest into <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteHolderMember_zJofx3FTRbJ3" title="Conversion shares">2,161,732 shares of common stock. Conversion of Preferred Shares During the six months ended June 30, 2026, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zeU3XLEpQQ2i">24,942,445 shares of Common Stock in connection with the conversion of 42.16 shares of Series B Preferred Stock. As of June 30, 2026, the Common Stock had been issued, while the corresponding cancellation of the Series B Preferred Stock remained pending. Although the administrative process related to the conversion had not been fully completed as of June 30, 2026, the common shares had been issued prior to period end. Subsequent to June 30, 2026, the shareholder completed the conversion of its entire holding of <span id="xdx_900_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20260815__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1vlgHFSK3kc" title="Preferred stock issued for conversion">66.50 shares of Series B Preferred Stock into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20260701__20260815__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHGO6UB4IF5k">39,314,218 shares of Common Stock. In connection with the completion of the conversion, duplicate shares of common stock were cancelled to reflect the appropriate number of shares issuable upon conversion. Accordingly, based on the substance of the transaction, the conversion of the 42.16 shares of Series B Preferred Stock is reflected in the accompanying financial statements as having occurred prior to June 30, 2026. Commitment/Contingency Shares During the six months ended June 30, 2026, the Company issued 12,500,000 shares of common stock per the settlement agreement signed in March 2026. (see Footnote 4). The value of these shares is $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHx40WCJRHM5" title="Number of shares issued for services, value">312,500. Deferred Stock-Based Compensation During the year ended November 30, 2024, the Company issued 10,000,000 shares of common stock for future services valued at $1,000,000. These shares were recorded as Deferred Stock-based compensation and the value of the shares is being amortized over three years. The value of the Deferred Stock-based compensation is an offset to Additional Paid in Capital. During the six months ended June 30, 2026, there was $166,666 amortization recorded. Subscription Receivable As of the six months ended June 30, 2026, the Company had issued shares valued at $20,950 for which funds had not yet been received. This subscription receivable is an offset to Additional Paid in Capital. Shares Cancelled During the six months ended June 30, 2026, the Company cancelled 15,556 shares of Reg A shares for a value of $1,000. These shares were part of the Regulation A offering. After the shares were issued, the investors challenged the investments. The Company cancelled the shares because of this challenge.

10000000

0.001

10000000

100000

super-voting with 10 votes

500

9900000

500

750

550

4137500

55166167

488358

350263

40053167

684900

28411342

547972

25000

5983

2161732

24942445

42.16

66.50

39314218

42.16

12500000

312500

10000000 1000000

166666

20950

15556

1000

Note 10 – Subsequent Events The Company has evaluated all transactions through the date the financial statements were issued for subsequent event disclosure or adjustment consideration. On July 28, 2026 the Company filed a Certificate of Amendment with the State of Nevada to increase the number of common shares from 1,000,000,000 to 2,000,000,000. Subsequent to the six months ending June 30, 2026, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzIgGgrPoYVb" title="Share issued">144,530,088 shares of common stock on the conversion of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zUlgLVl81Wj" title="Share issued">222.74 shares of preferred stock valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zYcIYBXOpbK" title="Share value issued">2,859,100. Subsequent to the six months ending June 30, 2026, the Company cancelled <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5Syy9wRooab" title="Share cancelled">24,942,445 shares of common stock valued at $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zC2qTONAnlRk" title="Share value cancelled">396,585. (See Note 9) Subsequent to the six months ending June 30, 2026, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentySixTermSheetsMember_zR3bR54VDG36" title="Share issued">2,500,000 shares of common stock valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentySixTermSheetsMember_zqVUZjdRDSp9" title="Share value issued">2,500 as per the Non-binding Term Sheets executed during the six months ended June 30, 2026. (See Note 7) Subsequent to the six months ending June 30, 2026, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TermSheetsAndExtensionNotesMember_zfRNtOEgMBjj" title="Share issued">2,500,000 shares of common stock valued at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TermSheetsAndExtensionNotesMember_zBGYQtVB7uj5" title="Share value issued">2,500 for extensions of the due date for the Non-binding Term Sheets and extension notes. (See Note 7) Subsequent to the six months ending June 30, 2026, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNTDnj5gWFGd" title="Share issued for services">2,000,000 shares of common stock valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260701__20260819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpehTYy2Iehb" title="Value issued for services">2,000 for services rendered. Subsequent to the six months ending June 30, 2026, the company issued 3,000,000 shares of common stock for cash of $3,000.

1000000000

2000000000

144530088

222.74

2859100

24942445

396585

2500000

2500

2500000

2500

2000000

2000

3000000

3000

false false false false